Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 197
Gene Symbol: AHSG
AHSG
0.010 AlteredExpression disease BEFREE In addition, patients with severe ED had lower fetuin-A levels than moderate and mild ED (P<0.001). 28424505 2017
Entrez Id: 9049
Gene Symbol: AIP
AIP
0.100 Biomarker disease HPO
Entrez Id: 207
Gene Symbol: AKT1
AKT1
0.220 Biomarker disease BEFREE Higher levels of phosphorylated protein kinase B (p-AKT)/protein kinase B (AKT) (<i>p</i> < 0.05) and B-cell lymphoma-2 (Bcl-2) and lower levels of the apoptosis factors Bcl2-associated x (Bax) and caspase-3 were observed in the MSC-treated group than in the DM ED group (<i>p</i> < 0.05). 30477146 2018
Entrez Id: 207
Gene Symbol: AKT1
AKT1
0.220 AlteredExpression disease BEFREE These results demonstrate that PDGF secretion by CCSMCs and vascular endothelial cells is enhanced under hypoxic conditions, leading to increased Cx43 expression through PI3K/AKT/β-catenin signaling and ultimately affecting GJ function in ED. 29174980 2018
Entrez Id: 207
Gene Symbol: AKT1
AKT1
0.220 Therapeutic disease RGD Over-activation of penile PARP pathway in diabetic rats enhances corporal apoptosis via energy depletion, suppression of Akt phosphorylation, and activation of the mitochondrial apoptotic pathway, which results in ED; these event could be prevented by treatment with 3-AB. 21235725 2011
Entrez Id: 213
Gene Symbol: ALB
ALB
0.020 GeneticVariation disease BEFREE Severe ED (62.8% vs 43.8%, <i>P</i>=0.037), mild-to-moderate ED (12.2% vs 5.2%, <i>P</i>=0.016), abdominal obesity (37.2% vs 22.9%, <i>P</i>=0.003), metabolic syndrome (38.4% vs 19.2%, <i>P</i>=0.026), proteinuria (0.83±0.68 vs 0.69±0.48 mg/dL, <i>P</i>=0.023), and C-reactive protein (6.1±4.9 vs 4.1±3.6 mg/L, <i>P</i><0.001) were high; high-density lipoprotein cholesterol (48.8±14.0 vs 52.6±13.5 mg/dL, <i>P</i>=0.009), and albumin (4.02±0.53 vs 4.18±0.38 g/dL, <i>P</i>=0.001) were low in the hypomagnesemia group. 28280316 2017
Entrez Id: 213
Gene Symbol: ALB
ALB
0.020 GeneticVariation disease BEFREE Age greater than 50 years, body mass index lower than 25, diabetes mellitus, stages IV/V of CKD, cardiac conduction disturbances, benign prostatic hyperplasia, smoking, alcohol use, albumin <3.5 g per 100 ml and creatinine clearance between 15 and 29 ml min<sup>-1</sup> per  1.73 m<sup>2</sup> were associated with ED. 28424504 2017
Entrez Id: 214
Gene Symbol: ALCAM
ALCAM
0.010 Biomarker disease BEFREE Other studies with larger sample sizes are required to determine whether ALCAM represents a novel gene in the pathogenesis of diabetes associated erectile dysfunction. 22704111 2012
Entrez Id: 501
Gene Symbol: ALDH7A1
ALDH7A1
0.030 GeneticVariation disease BEFREE The insertion/deletion (I/D) polymorphism in the angiotensin-converting enzyme gene (ACE) and the C825T polymorphism in the G-protein β3 subunit gene (GNB3) are associated with the efficacy of phosphodiesterase-5 inhibitor (PDE-5I) in erectile dysfunction. 26821322 2016
Entrez Id: 501
Gene Symbol: ALDH7A1
ALDH7A1
0.030 Biomarker disease BEFREE Seven plants in the top rank were selected from the "MANOSROI III" database using the two Thai keywords which meant impotence and sexual tonic.<i>Boesenbergia rotunda</i> (L.) Mansf. extract [EDP1-001(1)] gave the highest PDE inhibition activity of 4.36-fold sildenafil, a standard anti-impotence drug.<i>Plumbago indica</i> Linn. extract [EDP2-001(1)] exhibited the highest NO release stimulation activity of 666.85% which was 1.50-fold acetylcholine, a standard drug. 28811831 2017
Entrez Id: 501
Gene Symbol: ALDH7A1
ALDH7A1
0.030 Biomarker disease BEFREE The PDE-5i, like sildenafil, vardenafil and tadalafil, are effective in the treatment of ED with some benefits/ flexibilities and disadvantages compared to other treatment modalities. 28215172 2018
Entrez Id: 259
Gene Symbol: AMBP
AMBP
0.010 Biomarker disease BEFREE Comparison of UTI antibiograms stratified by ED patient  disposition. 28410918 2017
Entrez Id: 284
Gene Symbol: ANGPT1
ANGPT1
0.010 Biomarker disease BEFREE In the present study, we aimed to test if the combination of SVF and Ad-COMP-Ang1 could extend the erection effect in diabetic ED. 29667617 2019
Entrez Id: 285
Gene Symbol: ANGPT2
ANGPT2
0.010 Biomarker disease BEFREE MyD88 overexpression deteriorates cavernous structural damage, reduces ICP and ICP/MAP values and reverses the therapeutic effect of anti-TLR4 antibodies in rats with Ang-II-induced ED. 30484894 2018
Entrez Id: 3730
Gene Symbol: ANOS1
ANOS1
0.100 Biomarker disease HPO
Entrez Id: 367
Gene Symbol: AR
AR
0.020 AlteredExpression disease BEFREE MicroRNA-205 is associated with diabetes mellitus-induced erectile dysfunction via down-regulating the androgen receptor. 30729682 2019
Entrez Id: 367
Gene Symbol: AR
AR
0.020 GeneticVariation disease BEFREE The aim of this study is to evaluate the interaction of serum testosterone levels and AR CAG repeat polymorphism on the risk of ED in aging Taiwanese men. 26216079 2015
Entrez Id: 383
Gene Symbol: ARG1
ARG1
0.010 GeneticVariation disease BEFREE Similarly, the ARG1 GTCC haplotype is associated with higher IIEF scores in clinical ED. 26537638 2015
Entrez Id: 384
Gene Symbol: ARG2
ARG2
0.040 AlteredExpression disease BEFREE When compared to normal human cavernosal tissue, diabetic corpus cavernosum from humans with erectile dysfunction had higher levels of arginase II protein, gene expression, and enzyme activity. 11350073 2001
Entrez Id: 384
Gene Symbol: ARG2
ARG2
0.040 Biomarker disease BEFREE Given that human arginase II appears to play a role in regulating l-arginine bioavailability to NO synthase in human penile corpus cavernosum smooth muscle, the inhibition of human arginase II is a potential new strategy for the treatment of erectile dysfunction [Kim, N. N., Cox, J. D., Baggio, R. F., Emig, F. A., Mistry, S., Harper, S. L., Speicher, D. W., Morris, S. M., Ash, D. E., Traish, A. M., and Christianson, D. W. (2001) Biochemistry 40, 2678-2688]. 12859189 2003
Entrez Id: 384
Gene Symbol: ARG2
ARG2
0.040 Biomarker disease BEFREE Increased Arginase 2 concentrations were found in clinical ED and are associated with increased risk for ED. 26537638 2015
Entrez Id: 384
Gene Symbol: ARG2
ARG2
0.040 AlteredExpression disease BEFREE Serum Arginase II level can be a novel indicator for erectile dysfunction in patients with vasculogenic erectile dysfunction: a comparative study. 29956132 2018
Entrez Id: 472
Gene Symbol: ATM
ATM
0.010 GeneticVariation disease BEFREE Radiation reaction and radiation sensitivity contribute to ED and greater LUTS in men who have had brachytherapy for prostate cancer.This contribution is evident, e.g. in men with ataxia-telangiectasia (ATM) gene mutations. 17034599 2006
Entrez Id: 724066
Gene Symbol: ATXN8
ATXN8
0.100 Biomarker disease HPO
Entrez Id: 6315
Gene Symbol: ATXN8OS
ATXN8OS
0.100 Biomarker disease HPO